Trials / Terminated
TerminatedNCT00245544
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)
A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Study to Explore the Safety and Preliminary Efficacy of Oral MK0759 in the Treatment of Postherpetic Neuralgia
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety and effect of MK0759 in relieving neuropathic pain as experienced by patients with postherpetic neuralgia (PHN).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0759 |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2005-10-28
- Last updated
- 2015-05-21
Source: ClinicalTrials.gov record NCT00245544. Inclusion in this directory is not an endorsement.